Quarterly Result14 Nov 2025, 05:48 pm
Brawn Biotech Ltd Reports Q3 2025 Results: Revenue from Operations at INR 579.77 Million
AI Summary
Brawn Biotech Ltd has reported its financial results for the quarter and half year ended 30th September 2025. The company's revenue from operations stands at INR 579.77 Million. The Board of Directors approved these results in their meeting on 14th November 2025. The Statutory Auditors carried out a limited review for the quarter and half year ended 30th September 2025. The company is primarily engaged in the pharmaceuticals business and has prepared the financial results in compliance with the Indian Accounting Standards (Ind AS) and other recognized accounting practices.
Key Highlights
- Revenue from operations for Q3 2025 is INR 579.77 Million
- Board of Directors approved the results on 14th November 2025
- Limited review by Statutory Auditors for Q3 and half year 2025
- Financial results prepared in compliance with Ind AS and other recognized accounting practices
- Company primarily engaged in the pharmaceuticals business